Self-efficacy for symptom management in the acute phase of hematopoietic stem cell transplant: A pilot study

Lynn L. White, Kevin A. Kupzyk, Ann M. Berger, Marlene Z. Cohen, Philip J. Bierman

Research output: Contribution to journalArticle

Abstract

Purpose: Hematopoietic stem cell transplant (HSCT) is an intensive treatment associated with distressing treatment and disease-related symptoms that affect patient outcomes such as functional status and quality of life. Self-efficacy for symptom management (SESM) is a person's belief in their ability to perform behaviors to prevent and relieve symptoms. Presence of SESM can impact symptom distress and functional status. This study describes the changes over time and relationships among SESM, symptom distress, and physical functional status in adults during the acute phase of HSCT. Methods: Patients (n = 40) completed measures of symptom distress, SESM, and physical function at time points prior to and at days 7, 15 and 30 post-transplant. Clinical outcomes were length of stay and number of readmissions. Results: Symptom distress, physical function, and SESM changed significantly over time. There was a significant negative relationship between symptom distress and physical function and between symptom distress and SESM at all points. The lowest levels of SESM and physical function were at day 7 when symptom distress was highest. Symptom distress was a moderator for the relationship between physical function and SESM at day 15. Conclusion: This was the first study to examine SESM in the acute phase of HSCT. Higher SESM was associated with fewer symptoms and increased physical function. Less symptom distress was associated with higher physical function and confidence to manage symptoms. These findings provide the basis for development of patient-centered interventions to enhance SESM when symptoms are at their highest immediately after HSCT.

Original languageEnglish (US)
Pages (from-to)21-27
Number of pages7
JournalEuropean Journal of Oncology Nursing
Volume42
DOIs
StatePublished - Oct 2019

Fingerprint

Self Efficacy
Hematopoietic Stem Cells
Transplants
Aptitude
Length of Stay
Quality of Life

Keywords

  • Self-efficacy
  • Stem cell transplant
  • Symptom distress
  • Symptom management

ASJC Scopus subject areas

  • Oncology(nursing)

Cite this

@article{762470aeccc643519238a8a26f265e9d,
title = "Self-efficacy for symptom management in the acute phase of hematopoietic stem cell transplant: A pilot study",
abstract = "Purpose: Hematopoietic stem cell transplant (HSCT) is an intensive treatment associated with distressing treatment and disease-related symptoms that affect patient outcomes such as functional status and quality of life. Self-efficacy for symptom management (SESM) is a person's belief in their ability to perform behaviors to prevent and relieve symptoms. Presence of SESM can impact symptom distress and functional status. This study describes the changes over time and relationships among SESM, symptom distress, and physical functional status in adults during the acute phase of HSCT. Methods: Patients (n = 40) completed measures of symptom distress, SESM, and physical function at time points prior to and at days 7, 15 and 30 post-transplant. Clinical outcomes were length of stay and number of readmissions. Results: Symptom distress, physical function, and SESM changed significantly over time. There was a significant negative relationship between symptom distress and physical function and between symptom distress and SESM at all points. The lowest levels of SESM and physical function were at day 7 when symptom distress was highest. Symptom distress was a moderator for the relationship between physical function and SESM at day 15. Conclusion: This was the first study to examine SESM in the acute phase of HSCT. Higher SESM was associated with fewer symptoms and increased physical function. Less symptom distress was associated with higher physical function and confidence to manage symptoms. These findings provide the basis for development of patient-centered interventions to enhance SESM when symptoms are at their highest immediately after HSCT.",
keywords = "Self-efficacy, Stem cell transplant, Symptom distress, Symptom management",
author = "White, {Lynn L.} and Kupzyk, {Kevin A.} and Berger, {Ann M.} and Cohen, {Marlene Z.} and Bierman, {Philip J.}",
year = "2019",
month = "10",
doi = "10.1016/j.ejon.2019.07.006",
language = "English (US)",
volume = "42",
pages = "21--27",
journal = "European Journal of Oncology Nursing",
issn = "1462-3889",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Self-efficacy for symptom management in the acute phase of hematopoietic stem cell transplant

T2 - A pilot study

AU - White, Lynn L.

AU - Kupzyk, Kevin A.

AU - Berger, Ann M.

AU - Cohen, Marlene Z.

AU - Bierman, Philip J.

PY - 2019/10

Y1 - 2019/10

N2 - Purpose: Hematopoietic stem cell transplant (HSCT) is an intensive treatment associated with distressing treatment and disease-related symptoms that affect patient outcomes such as functional status and quality of life. Self-efficacy for symptom management (SESM) is a person's belief in their ability to perform behaviors to prevent and relieve symptoms. Presence of SESM can impact symptom distress and functional status. This study describes the changes over time and relationships among SESM, symptom distress, and physical functional status in adults during the acute phase of HSCT. Methods: Patients (n = 40) completed measures of symptom distress, SESM, and physical function at time points prior to and at days 7, 15 and 30 post-transplant. Clinical outcomes were length of stay and number of readmissions. Results: Symptom distress, physical function, and SESM changed significantly over time. There was a significant negative relationship between symptom distress and physical function and between symptom distress and SESM at all points. The lowest levels of SESM and physical function were at day 7 when symptom distress was highest. Symptom distress was a moderator for the relationship between physical function and SESM at day 15. Conclusion: This was the first study to examine SESM in the acute phase of HSCT. Higher SESM was associated with fewer symptoms and increased physical function. Less symptom distress was associated with higher physical function and confidence to manage symptoms. These findings provide the basis for development of patient-centered interventions to enhance SESM when symptoms are at their highest immediately after HSCT.

AB - Purpose: Hematopoietic stem cell transplant (HSCT) is an intensive treatment associated with distressing treatment and disease-related symptoms that affect patient outcomes such as functional status and quality of life. Self-efficacy for symptom management (SESM) is a person's belief in their ability to perform behaviors to prevent and relieve symptoms. Presence of SESM can impact symptom distress and functional status. This study describes the changes over time and relationships among SESM, symptom distress, and physical functional status in adults during the acute phase of HSCT. Methods: Patients (n = 40) completed measures of symptom distress, SESM, and physical function at time points prior to and at days 7, 15 and 30 post-transplant. Clinical outcomes were length of stay and number of readmissions. Results: Symptom distress, physical function, and SESM changed significantly over time. There was a significant negative relationship between symptom distress and physical function and between symptom distress and SESM at all points. The lowest levels of SESM and physical function were at day 7 when symptom distress was highest. Symptom distress was a moderator for the relationship between physical function and SESM at day 15. Conclusion: This was the first study to examine SESM in the acute phase of HSCT. Higher SESM was associated with fewer symptoms and increased physical function. Less symptom distress was associated with higher physical function and confidence to manage symptoms. These findings provide the basis for development of patient-centered interventions to enhance SESM when symptoms are at their highest immediately after HSCT.

KW - Self-efficacy

KW - Stem cell transplant

KW - Symptom distress

KW - Symptom management

UR - http://www.scopus.com/inward/record.url?scp=85069947826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069947826&partnerID=8YFLogxK

U2 - 10.1016/j.ejon.2019.07.006

DO - 10.1016/j.ejon.2019.07.006

M3 - Article

C2 - 31446260

AN - SCOPUS:85069947826

VL - 42

SP - 21

EP - 27

JO - European Journal of Oncology Nursing

JF - European Journal of Oncology Nursing

SN - 1462-3889

ER -